tirzepatide day 1 Microdosing Chart: A Weekly Dose Guide That Works Navigating Tirzepatide Dosing: Can I

When to Seek Medical Advice About Swelling or Fluid Retention While water retention is not a typical side effect of GLP-1 receptor agonists, any new or worsening swelling warrants medical evaluation to identify the underlying cause and ensure patient safety

While initially used for type 2 diabetes, semaglutide (specifically at a higher dose under the brand name Wegovy) is approved for weight management in individuals with obesity or who are overweight with at least one weight-related condition

[DOI] [PMC free article] [PubMed] [Google Scholar] 54.Zhu J, Huang T, Lombard JH

Compounded semaglutide is not FDA-approved, and its safety, effectiveness, and quality have not been reviewed by the FDA

The "Start Low" Approach (Resetting to Introduction Doses) Semaglutide and tirzepatide both follow titrated dosing schedules, where healthcare providers prescribe a low starting dose and gradually increase from there based on your response to the medication and tolerance for side effects